Un nouvel article publié dans Cancers :
Novel Insights into Redox-Based Mechanisms for Auranofin-Induced Rapid Cancer Cell Death
Abstract
Auranofin (Ridaura®, AUF) is a gold complex originally approved as an antirheumatic agent that has emerged as a potential candidate for multiple repurposed therapies. The best-studied anticancer mechanism of AUF is the inhibition of thioredoxin reductase (TrxR). However,…
